Upcoming Medical Conferences in Austria

6th ESRA Pain Cadaver Workshop and 29th ESRA RA Cadaver Workshop is organized by Kenes Group and will be held from Feb 20 - 23, 2019 at Anatomical Museum / Medical University of Innsbruck, Innsbruck, Tyrol, Austria. This CME Conference has been approved for a maximum of 7 Credits. Target Audience: The target audience includes international, regional and national clinical practitioners, residents/research fellows who are practicing in the field of regional anaesthesia. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels experience.  Educational Objectives: After attending this event, participants should be able to: • Address individual needs in compliance with their Continuous Professional Development (CPD) plan. • Enhance practical knowledge in the medical field of pain management. • Differentiate surrounding tissue to increase precision as well as safety of the learned procedures. • Apply practical skill in operating ultrasound systems and identifying target structures. • Demonstrate needle placement under ultrasound guidance. • Participate in a dialogue between clinicians and researchers in the field of pain management as a means of further developing individual expertise. Additional details will be posted as soon as they are available.

25th European Congress of Radiology (ECR) is organized by European Society of Radiology (ESR) and will be held from Feb 27 - Mar 03, 2019 at Austria Center, Vienna, Wien, Austria. Additional details will be posted as soon as they are available.

The International Congress on Controversies in Fibromyalgia (Fibromyalgia2019) is organized by Bioevents and will be held from Mar 04 - 05, 2019 at Hilton Vienna, Vienna, Wien, Austria. Target audience: • Medical Professionals • R&D personnel  • CEOs • Regulatory Affairs specialists   • CROs  • CRAs • QA personnel • Research facility managers • Pharmaceutical Company representatives • Start-up Companies Conference Description: Fibromyalgia2019 will aim at both exposing and (hopefully) shedding constructive light on some of these more central controversies, aiming at both honoring diversity of opinion as well as attempting to forge understanding and a basis for collaboration down the road.  The Congress will welcome researchers, clinicians, Fibromyalgia specialists, treatment experts, pharmaceutical companies and other industry leaders. The congress will focus on the following key areas: • The neurobiological underpinnings of fibromyalgia and centralized pain  • Classification, diagnosis, epidemiology and the evolving concept of fibromyalgia • Genetics, pharmacogenetics, and epigenetics in the understanding of fibromyalgia • Treating fibromyalgia, conventionally as well as not • Combining diverse lines of research in the study of complex CNS – related conditions such as fibromyalgia • Dealing with "transparent pain": How society deals with fibromyalgia Additional details will be posted as soon as they are available.

The 2nd International Congress on Advanced Treatments in Rare Diseases (RARE2019) is organized by Bioevents and will be held from Mar 04 - 05, 2019 at Hilton Vienna, Vienna, Wien, Austria. Conference Description: RARE2019 will follow on from the success of its predecessor, addressing the challenges of Rare Diseases Treatments as well as new therapies on the horizon. It will expand on so-called "generic topics", such as clinical trials' design, funding for research, digital health, big data on the one hand and focusing on the individual patients for innovation in both drug development and management. This Congress is excited to welcome world-renowned speakers, all of whom are experts in the field of Rare Diseases and who will present ground-breaking and cutting-edge news on treatments in Rare Diseases.   This year the Scientific Committee will present a Best Abstract Award to the top 3 submitted abstracts. Abstract topics include: ​• General challenges in rare disease • Patients focused aspects in rare diseases • Rare syndromes • Single gene diseases • Relations between rare diseases and common disorders • Miscellaneous rare diseases • New treatment modalities • Role of registries and big data • Ethical aspects in rare diseases • Raising awareness for rare diseases RARE2019 is a congress suitable for scientists and clinicians, pharmaceutical, clinical research organisations, research networks and other medical professionals. Additional details will be posted as soon as they are available.  

The European Congress on Innovation in Diabetes (Diabetes-Innovations2019) is organized by Bioevents and will be held from Mar 04 - 05, 2019 at Hilton Vienna, Vienna, Wien, Austria.   Target Audience: • Medical Professionals • R&D personnel  • CEOs • Regulatory Affairs specialists   • QA personnel • Research facility managers • Pharmaceutical Company representatives • Start-Up Companies   Conference Description: Diabetes technology has developed over the last decades to become an essential component of diagnosis and care for patients with diabetes mellitus.  New technologies derived from space travel and computer science are soon to be married with existing technology applications to make closed loop systems, artificial pancreas and other emerging treatment options to become real and not only virtual reality. Diabetes-Innovations2019 will welcome medical professionals, R&D personnel, treatment experts, industry leaders and other experts to the majestic city of Vienna. The Congress will focus on three main areas: • Provide a comprehensive overview over the emerging field of new current technology developments as innovative physico-chemical methods in the field of microelectronic mechanic systems and nanotechnology that have finally also reached the diabetes space. • Provide a comprehensive understanding regarding current approaches to integrate diabetes diagnostics and treatment information to provide real integrated patient care by using the emerging potential of wireless data collection and analysis for effective and safe applications to improve patient healthcare. • Provide a presentation platform for current non-invasive device developments and applications for assessment of glucose, cardiovascular parameters and other body signals.  Additional details will be posted as soon as they are available.

Faculty of Forensic Psychiatry Annual Conference is organized by Royal College of Psychiatrists (RCPSYCH) and will be held from Mar 06 - 08, 2019 at Hilton Vienna, Vienna, Wien Austria. The target audience for this medical event is for all Faculty members and any medical health professional with a special interest in forensic psychiatry. CPD: One CPD point per hour of educational activity, subject to peer group approval​ Preconference Workshop: 05 March 2019 Additional details will be posted as soon as they are available.

16th St. Gallen International Breast Cancer Conference is organized by Mondial Congress and Events, St. Gallen Oncology Conferences (SONK) and will be held from Mar 20 - 23, 2019 at Austria Center, Vienna, Wien, Austria. Conference Description: For many years the traditional conference, which attracts close to 3.000 delegates from all over the globe, has set the benchmark in primary therapy of early breast cancer. The conference is renowned for its high level of quality as well as its top speakers representing the best in breast cancer research and therapy worldwide. The highlight of the Congress is the St. Gallen Breast Cancer Consensus, in which up to 60 experts gather on stage to engage in a live-voting process on therapy of early breast cancer, which shapes treatment procedures for the coming two years. Participants are sure to witness history in the making for the good of breast cancer patients worldwide. The conference, which will be held in Vienna, Austria for the third time, combines the best of Swiss precision and thoroughness with the strengths of Vienna as a destination: a centrally located meeting place of cultures, which attracts researchers and clinicians from all over the world. In addition, Vienna is a treasure trove of culture and history. Be it music, architecture or cuisine, there will not be a dull moment during congress hours and after. The event is supported by an industry exhibition, showcasing the latest technology for breast cancer diagnosis and care. Industry will also have the opportunity to hold their own activities for the benefit of attendees. Abstracts are accepted from August 31 2018. The submission period ends on 15 December 2018. The conference is pending to be accredited with around 18 CME credits. Speakers: Fabrice Andrè, Harry Bartelink, Jose Baselga, Harold J. Burstein, Fatima Cardoso, Lisa Carey, Boon Chua, Javier Cortes, Andrea De Censi, Carsten Denkert, Angelo Di Leo, Matthew Ellis, Dame Lesley Fallowfield, Florian Fitzal, Prudence Francis, Judy Garber, Sharon Giordano, Michael Gnant, Bahadir Gulluoglu, Nadia Harbeck, Shelley Hwang, Stephen Johnston, Tari King, Ian Krop, Sherene Loi, John H Maduro, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith Regan, Hope Rugo, Emiel J.T. Rutgers, Ivana Sestak, Christos Sotiriou, Fraser Symmans, Nicholas Turner, Andrew Tutt, Paolo Veronesi, Giuseppe Viale, Timothy Whelan, Eric P. Winer, Antonio C Wolff Additional details will be posted as soon as they are available.

Bio-Europe Spring - 13th Annual International Partnering Conference is organized by EBD Group and will be held from Mar 25 - 27, 2019 at Messe Wien Exhibition Congress Center, Vienna, Wien, Austria. Who will you meet? BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. Additional details will be posted as soon as they are available.

Microbiome Therapeutics Europe is organized by KNect365 Life Sciences and will be held from Mar 28 - 29, 2019 at Courtyard by Marriott Vienna Prater/Messe, Vienna, Wien, Austria. Course Description: This conference leaders from across the field of microbiome therapeutics will gathering in Vienna to discuss the latest research, developments and discoveries in the pursuit to translate the power of the human microbiome into commercially viable medicines. Over 2 days, Microbiome Therapeutics Europe will explore the ins and outs of emerging technologies, learnings from clinical trials, regulatory hurdles and commercial challenges to help you gain the information and connections you need to take your pipeline to the next level.  Join the likes of AOBiome, AMC Amsterdam, Merck, Eligo Bioscience, The BioCollective, BioMarketing Insight, Evolve Biosystems Inc. and more for practical industry insights, and discuss manufacturing and formulation strategies to take these projects from concepts to market. Plus, stay up-to-date of the regulatory framework developments and seek out investment opportunities to ensure you're equipped with the information you need for your products to succeed. For sponsorship and exhibition opportunities please contact Perri.Lucatello@KNect365.com Time: 08:00 to 16:20 Speakers: Larry Weiss, CEO and Founder at Persona Biome, Raul Cano, CSO at The BioCollective, Todd Krueger, Chief Executive Officer and President at AOBiome, Xavier Duportet, CEO at Eligo Bioscience, Regine Au, Principal at BioMarketing Insight, Michel De Baar, Executive Director, Business Development, Europe at Merck, Wouter De Jonge, Professor of NeuroGastroenterology at AMC Amsterdam, Marielle Fournier, Senior Director, Drugs, Devices and Combination Products at Voisin Consulting Life Sciences, Philippe Galant, CSO at SYNGULON, François Gianelli, Associate Director at Voisin Consulting Life Sciences, Scott Jackson, Leader - Complex Microbial Systems Group, Biosystems and Biomaterials Division at National Institute of Standards and Technology, Nikole Kimes, Founder/Vice President at Siolta Therapeutics, David Kyle, Chairman and CSO at Evolve Biosystems Inc., Daniel McDonald, Scientific Director at American Gut Project, Julian Riba, CSO at Cytena, Ricardo Valladares, Vice President, Research and Development at Siolta Therapeutics, Momo Vuyisich, Chief Science Officer at Viome, Inc Additional details will be posted as soon as they are available.

AOTrauma Masters Symposium DACH-Complications & Infections is organized by AOTrauma and will be held from Apr 01 - 02, 2019 at Vienna, Wien, Austria. Additional details will be posted as soon as they are available.